Enhanced Topical Copper Ion Treatments for Dermatological Conditions

Publication ID: 24-11857514_0001_PTD

Published: October 28, 2025

Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Topical Copper Ion Treatments for Dermatological Conditions,” Published Technical Disclosure No. 24-11857514_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857514_0001_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,514.

Summary of the Inventive Concept

The present inventive concept relates to improved topical copper ion treatments for dermatological conditions, addressing the limitations of existing treatments by enhancing copper ion bioavailability, stability, and delivery. The inventive concept provides a range of novel formulations, methods, and systems for optimizing copper ion treatment outcomes.

Background and Problem Solved

The original patent disclosed topical copper ion treatments for dermatological conditions, but had limitations in terms of copper ion bioavailability, stability, and delivery. The present inventive concept addresses these limitations by introducing novel formulations, methods, and systems that enhance the efficacy and efficiency of copper ion treatments.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of novel aspects, including: (1) a biocompatible solution with a pH range of 4.5 to 5.5 to enhance copper ion bioavailability and stability; (2) a method for optimizing copper ion delivery by selecting copper metals with specific surface areas and controlling temperature and incubation time; (3) a copper ion-containing solution with a concentration of at least 50 milligrams per 7.44 ounces of solution and a humectant to enhance skin hydration and copper ion absorption; (4) a topical copper ion treatment composition with a copper ion suspension, a carrier agent, and a penetration enhancer to facilitate deeper skin penetration; and (5) a method for real-time monitoring of copper ion concentrations using a copper ion-sensitive indicator. These novel aspects work together to provide improved treatment outcomes for dermatological conditions.

Novelty and Inventive Step

The present inventive concept is novel and non-obvious compared to the original patent, as it introduces a range of new formulations, methods, and systems that address the limitations of existing copper ion treatments. The inventive concept's focus on enhancing copper ion bioavailability, stability, and delivery provides a significant improvement over existing treatments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the pH range of the biocompatible solution, using different copper metal surface areas, or incorporating additional ingredients to enhance skin hydration and copper ion absorption. Variations of the method for optimizing copper ion delivery could include adjusting temperature and incubation time or using different copper ion concentrations.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the dermatological treatment market, particularly for conditions such as acne, eczema, and fungal infections. The improved efficacy and efficiency of the inventive concept's copper ion treatments could lead to increased adoption and market share.

CPC Classifications

Section	Class	Group
A	A61	A61K33/34
A	A61	A61K9/0014
A	A61	A61K9/0031
A	A61	A61K9/0034
A	A61	A61K9/02
A	A61	A61K9/06
A	A61	A61L15/44
A	A61	A61L17/005
A	A61	A61L26/0066
A	A61	A61L26/0076
A	A61	A61L2300/102

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Dermatological treatments involving topical copper ion compositions, with expertise in pharmaceutical formulation, materials science, and transdermal drug delivery systems

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences or chemical engineering, experienced in developing topical medical treatments, familiar with metal ion delivery mechanisms, and skilled in formulation optimization techniques

Obviousness Rationale

A person of ordinary skill would recognize that the PTD's variations represent predictable engineering modifications to the source patent's copper ion treatment methodology. The disclosed enhancements in pH control, metal surface area selection, and penetration mechanisms represent standard optimization strategies within pharmaceutical formulation. These variations would be considered routine design choices for a skilled practitioner seeking to improve copper ion delivery and treatment efficacy.

Obvious Combinations & Variations

Source Patent Element

Copper ion suspension for treating bacterial infections

PTD Variation

Introducing a specific pH range of 4.5 to 5.5 to enhance copper ion bioavailability

Obviousness Reasoning

Adjusting solution pH to optimize ion stability is a known technique in pharmaceutical formulation, representing a predictable variation that would yield expected results

Source Patent Element

Topical application of copper ion treatments

PTD Variation

Adding a penetration enhancer to facilitate deeper skin penetration

Obviousness Reasoning

Incorporating penetration enhancers is a standard approach in transdermal drug delivery to improve active ingredient absorption, representing a known technique with predictable outcomes

Source Patent Element

Copper ion suspension in various delivery formats

PTD Variation

Introducing a humectant to enhance skin hydration and copper ion absorption

Obviousness Reasoning

Modifying topical formulations with hydrating agents is a common pharmaceutical strategy to improve drug delivery and skin interaction, constituting an obvious design choice

Source Patent Element

Copper ion treatment method

PTD Variation

Controlling copper metal surface area and incubation parameters to optimize ion leaching

Obviousness Reasoning

Manipulating metal surface characteristics and processing conditions represents a standard engineering approach to improving ion generation, constituting a predictable optimization technique

Source Patent Element

Topical copper ion treatment

PTD Variation

Implementing a real-time copper ion concentration monitoring method using sensitive indicators

Obviousness Reasoning

Developing in-situ monitoring techniques is a routine approach in pharmaceutical development, representing an obvious extension of existing treatment methodologies

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857514 and the disclosed variations, a person of ordinary skill in the art would find the claimed topical copper ion treatment techniques obvious and anticipated. The published technical disclosure demonstrates that the claimed innovations represent predictable engineering modifications within the established pharmaceutical formulation domain, thereby rendering subsequent similar claims obvious and unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent Number	US 11,857,514
Title	Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
Assignee(s)	CDA RESEARCH GROUP, INC.